Boehringer Ingelheim Pharmaceuticals
UEI: GH4RRVR2FHS7
• CAGE: 55391
Overview
Parent Awardee
Name
Boehringer Ingelheim Pharmaceuticals
Headquarters
Ridgefield, CT
United States
United States
Most Recent Award
Sept. 15, 2022
Calculating
Federal contract recipient
BOEHRINGER INGELHEIM PHARMACEUTICALS INC
dba BOEHRINGER INGELHEIM PHARMACEUTICALS INC
(UEI GH4RRVR2FHS7, CAGE 55391)
is headquartered in Ridgefield CT.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in March 1971 and
federally registered in
July 2001.
Federal Award Analysis
Boehringer Ingelheim Pharmaceuticals federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
BOEHRINGER INGELHEIM PHARMACEUTICALS INC
DBA
BOEHRINGER INGELHEIM PHARMACEUTICALS INC
UEI
GH4RRVR2FHS7
CAGE Code
55391
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
March 2, 1971
Initial Registration
July 18, 2001
Last Registration
Nov. 29, 2024
Registration Activation
May 20, 2024
Registration Expiration
May 16, 2025
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Reported PSC
Accepts Credit Cards
Yes
People
Vendor contacts at Boehringer Ingelheim Pharmaceuticals
GSA Schedules and Price Lists
- Boehringer Ingelheim Pharmaceuticals
- PoP: 9/14/22 - 9/14/27
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Boehringer Ingelheim Pharmaceuticals
- PoP: 3/31/15 - 9/14/22 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $4,320